1. Home
  2. NVNI vs MYO Comparison

NVNI vs MYO Comparison

Compare NVNI & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nvni Group Limited

NVNI

Nvni Group Limited

HOLD

Current Price

$1.94

Market Cap

32.9M

Sector

N/A

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$0.89

Market Cap

36.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVNI
MYO
Founded
2019
2004
Country
Brazil
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.9M
36.9M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
NVNI
MYO
Price
$1.94
$0.89
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
139.7K
557.1K
Earning Date
09-30-2025
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,250,627.00
$41,643,203.00
Revenue This Year
$12.05
$24.07
Revenue Next Year
$15.02
$17.48
P/E Ratio
N/A
N/A
Revenue Growth
1491.58
65.00
52 Week Low
$1.44
$0.71
52 Week High
$75.80
$6.44

Technical Indicators

Market Signals
Indicator
NVNI
MYO
Relative Strength Index (RSI) 29.90 41.61
Support Level $1.60 $0.92
Resistance Level $3.18 $1.02
Average True Range (ATR) 0.24 0.07
MACD -0.09 -0.01
Stochastic Oscillator 21.52 17.58

Price Performance

Historical Comparison
NVNI
MYO

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: